Mycobacterium tuberculosis DNA in living donor transplanted livers and donor-related tuberculosis in recipients: A retrospective longitudinal cohort study.

Objectives: Mycobacterium tuberculosis DNA has been detected in multiple organs in people without active tuberculosis or a history of tuberculosis. Molecular testing for metabolic activity has suggested that M tuberculosis DNA represents viable bacilli. Whether transplanted organs with M tuberculosis DNA can result in tuberculosis in recipients has not been assessed.

Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population.

Objectives: Allograft outcome can be improved with the discovery of risk factors that influence adverse events and may allow individualization of patients' treatment. Rejection is the main hurdle to successful transplantation and the immune response is the key effecter to rejection development. Hence, the major objective of the present study was to assess the relationship between single nucleotide polymorphisms (SNPs) in 5 cytokine genes, HLA mismatch and graft outcome in a cohort of 100 Saudi kidney transplant recipients and 100 living related donors at a single transplant center.

Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C.

Background & Aims: Interferon (IFN)-based therapy in chronic hepatitis C virus (HCV)-infected renal transplant (RT) recipients has been associated with a high risk of acute allograft rejection (AAR) and poor efficacy. We assessed the safety and efficacy of PegIFNα-2a and ribavirin (RBV) combination therapy in HCV-infected RT recipients.

Methods: Thirty-two adult RT recipients of >12-month duration, infected with HCV genotypes 1 (62.

The kidney transplant program at king faisal specialist hospital and research center.

The Kidney Transplant Program at the King Faisal Specialist Hospital and Research Center (KFSH&RC), Riyadh was launched in 1981 when the first living-donor (LD) kidney transplant was performed in the center. The first deceased-donor (DD) kidney transplant was performed in 1982, and the first simultaneous kidney-pancreas (SPK) in 2004. As of February 2005, more than 1,000 kidney transplants (654 living-donor and 347 deceased-donor) have been performed.

The Kidney Transplant Program at King Faisal Specialist Hospital and Research Center.

More than 1,000 kidney transplants were performed at King Faisal Specialist Hospital and Research Center (KFSH&RC) between 1981-2005. The majority were from living donors. The renal transplant program at KFSH&RC was fundamentally transformed in 2001 with the introduction of renal transplant physicians and the emphasis on multidisciplinary teamwork.

Kaposi's sarcoma in Sudanese renal transplant recipients: a report from a single center.

Background: The incidence of Kaposi's sarcoma (KS) in Sudanese renal transplant recipients is not known.

Methods: We retrospectively assessed the prevalence of KS in 30 Sudanese renal transplant recipients followed for 16 years.

Results: Four patients (13.